How frequently and how soon should we screen our patients for the presence of antimalarial retinopathy?
Open Access
- 5 February 2002
- journal article
- letter
- Published by Wiley in Arthritis & Rheumatism
- Vol. 46 (2) , 561
- https://doi.org/10.1002/art.10054
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Detection and Prevention of Maculopathy Associated with Antimalarial AgentsInternational Ophthalmology Clinics, 1999
- Hydroxychloroquine retinopathy: is screening necessary?BMJ, 1998
- Incidence of hydroxychloroquine retinopathy in 1,207 patients in a large multicenter outpatient practiceArthritis & Rheumatism, 1997
- Guidelines for monitoring drug therapy in rheumatoid arthritisArthritis & Rheumatism, 1996
- Retinal toxicity in long term hydroxychloroquine treatment.Annals of the Rheumatic Diseases, 1996
- Use of hyperbaric oxygen in rheumatic diseasesLupus, 1996
- Warts and Lupus ErythematosusLupus, 1993